vACcine COnfidence amongst those living with alleRgy during the COVID pandemic (ACCORD): a scoping review protocol

Simple item page
dc.contributor.authorGolding, Michael A.
dc.contributor.authorAskin, Nicole
dc.contributor.authorBatac, Ayel L. R.
dc.contributor.authorMerrill, Kaitlyn A.
dc.contributor.authorAbrams, Elissa M.
dc.contributor.authorBégin, Philippe
dc.contributor.authorBen-Shoshan, Moshe
dc.contributor.authorLadouceur, Erika
dc.contributor.authorRoos, Leslie E.
dc.contributor.authorProtudjer, Vladan
dc.contributor.authorProtudjer, Jennifer L. P.
dc.date.accessioned2022-10-01T03:33:09Z
dc.date.issued2022-09-18
dc.date.updated2022-10-01T03:33:09Z
dc.description.abstractAbstract Background Reports of allergic reactions to the COVID-19 vaccines have been documented, which may also contribute to hesitancy. Despite the low likelihood that the COVID-19 vaccine will trigger an allergic reaction, we and others have reported that families with allergy remain vaccine hesitant due to concerns of COVID-19-vaccine-triggered anaphylaxis. Objective To present our scoping review protocol, that will inform a forthcoming living scoping review in which we will investigate the peer-reviewed and grey literature on COVID-19 vaccine hesitancy and allergic disease and/or allergic reactions following a COVID-19 vaccine. Methods Informed by Arksey and O’Malley framework for methodological review, we have developed a search strategy with content and methodological experts, and which has undergone Peer Review of Electronic Search Strategies review. A search of four scientific databases, as well as gray literature, will be performed without restriction to articles by type of COVID-19 vaccine, or country of study, and will include publications in the ten languages our team can handle. Bi-monthly search alerts based on the search strategy will be generated. Results The first search will result in a stand alone peer reviewed scoping review. Bi-monthly updates will be posted on a pre-print server. Depending on the volume of literature, these updates will be synthesized and submitted for peer-review at 6 and/or 12 months. Conclusion COVID-19 vaccine hesitancy amongst individuals with allergy persists, despite very low risk of serious adverse reactions. Our living scoping review, which includes multiple forms of knowledge translation, will be a rigorous way to address hesitancy.
dc.identifier.citationAllergy, Asthma & Clinical Immunology. 2022 Sep 18;18(1):83
dc.identifier.urihttps://doi.org/10.1186/s13223-022-00723-w
dc.identifier.urihttp://hdl.handle.net/1993/36940
dc.language.rfc3066en
dc.rightsopen accessen_US
dc.rights.holderThe Author(s)
dc.titlevACcine COnfidence amongst those living with alleRgy during the COVID pandemic (ACCORD): a scoping review protocol
dc.typeJournal Article
local.author.affiliationRady Faculty of Health Sciencesen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
13223_2022_Article_723.pdf
Size:
625.41 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.24 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
University of Manitoba Scholarship
Rady Faculty of Health Sciences Scholarly Works